Environmental Causes of Human Spongiform Encephalopathy

[1]  P. Brown,et al.  Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[2]  H. Rieder,et al.  Incidence of Creutzfeldt-Jakob disease , 1994, The Lancet.

[3]  P. Brown,et al.  Human spongiform encephalopathy: The national institutes of health series of 300 cases of experimentally transmitted disease , 1994, Annals of neurology.

[4]  A. Alpérovitch,et al.  Incidence of Creutzfeldt-Jakob disease In Europe in 1993 , 1994, The Lancet.

[5]  D. Dormont,et al.  Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease , 1994, The Lancet.

[6]  B. Crain,et al.  Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. , 1994, Neurosurgery.

[7]  M. Hara,et al.  Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. , 1994, Neurosurgery.

[8]  P. Brown,et al.  Iatrogenic Creutzfeldt‐Jakob disease , 1994, Neurology.

[9]  C. Lueck,et al.  Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[10]  L. Dumble,et al.  Transmission of Creutzfeldt-Jakob disease by blood transfusion , 1993, The Lancet.

[11]  S. Sawcer,et al.  Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE , 1993, The Lancet.

[12]  J. Fradkin.  Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients , 1993 .

[13]  P. Brown,et al.  Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. , 1993, The New England journal of medicine.

[14]  N. Heye,et al.  Creutzfeldt-Jakob disease and blood transfusion , 1993, The Lancet.

[15]  M. Palmer,et al.  Transmission of Creutzfeldt-Jakob disease by handling of dura mater , 1993, The Lancet.

[16]  N. J. David,et al.  Creutzfeldt‐Jakob disease in a physician , 1993, Neurology.

[17]  M. Genuardi,et al.  Creutzfeldt-Jakob disease after non-commercial dura mater graft , 1992, The Lancet.

[18]  F. Taguchi,et al.  Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease. , 1992, The New England journal of medicine.

[19]  J. Goujard,et al.  Epidemiologic survey of patients treated with growth hormone in France in the period 1959-1990: preliminary results. , 1992, Hormone research.

[20]  D. G. Gorman,et al.  Creutzfeldt‐Jakob disease in a pathologist , 1992, Neurology.

[21]  H. Willison,et al.  Creutzfeldt-Jacob disease following cadaveric dura mater graft. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[22]  M. Palmer,et al.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.

[23]  T. Miyatake,et al.  Creutzfeldt‐Jakob disease in a patient with a cadaveric dural graft , 1991, Neurology.

[24]  A. Buescu,et al.  Pituitary growth hormone and Creutzfeldt-Jakob disease. , 1991, BMJ.

[25]  M. Preece,et al.  Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. , 1991, BMJ.

[26]  P. Blumbergs,et al.  Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. , 1990, Australian and New Zealand journal of medicine.

[27]  P. Liberski,et al.  Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. , 1990, The Journal of infectious diseases.

[28]  G. Macchi,et al.  Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. , 1989, Journal of neurosurgery.

[29]  H. Diringer,et al.  INFECTIVITY OF UNCONVENTIONAL VIRUSES IN DURA MATER , 1989, The Lancet.

[30]  R. Kalb,et al.  Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. , 1988, Journal of neurosurgery.

[31]  S. Cousens,et al.  Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[32]  E. Hedley‐Whyte,et al.  Preclinical Creutzfeldt‐Jakob disease discovered at autopsy in a human growth hormone recipient , 1988, Neurology.

[33]  P. Brown,et al.  A new case of Creutzfeldt‐Jakob disease associated with human growth hormone therapy in New Zealand , 1988, Neurology.

[34]  P. Castaigne,et al.  The epidemiology of Creutzfeldt‐Jakob disease , 1987, Neurology.

[35]  E. Hedley‐Whyte,et al.  Neuropathologic verification of Creutzfeldt‐Jakob disease in the exhumed American recipient of human pituitary growth hormone , 1986, Neurology.

[36]  P. Brown,et al.  Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. , 1986, The Journal of infectious diseases.

[37]  P. Steart,et al.  PATHOLOGY OF CREUTZFELDT‐JAKOB DISEASE ASSOCIATED WITH PITUITARY‐DERIVED HUMAN GROWTH HORMONE ADMINISTRATION , 1986, Neuropathology and applied neurobiology.

[38]  J. Tateishi.  TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN BLOOD AND URINE INTO MICE , 1985, The Lancet.

[39]  E. Manuelidis,et al.  TRANSMISSION TO ANIMALS OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN BLOOD , 1985, The Lancet.

[40]  P. Brown.  VIRUS STERILITY FOR HUMAN GROWTH HORMONE , 1985, The Lancet.

[41]  J. Parisi,et al.  Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. , 1985, The New England journal of medicine.

[42]  P. Brown,et al.  Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. , 1985, The New England journal of medicine.

[43]  B. Berg,et al.  Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. , 1985, The New England journal of medicine.

[44]  M. Preece,et al.  CREUTZFELDT-JAKOB DISEASE AFTER ADMINISTRATION OF HUMAN GROWTH HORMONE , 1985, The Lancet.

[45]  H. Fraser,et al.  PREPARATION OF GROWTH HORMONE FREE FROM CONTAMINATION WITH UNCONVENTIONAL SLOW VIRUSES , 1985, The Lancet.

[46]  D. Kingsbury,et al.  Chemical disinfection of Creutzfeldt-Jakob disease virus. , 1982, The New England journal of medicine.

[47]  P. Brown,et al.  Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus. , 1982, The Journal of infectious diseases.

[48]  R. Will,et al.  Evidence for case-to-case transmission of Creutzfeldt-Jakob disease , 1982, Journal of neurology, neurosurgery, and psychiatry.

[49]  C. Masters,et al.  Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease). Atypical clinical and pathological findings. , 1981, Archives of neurology.

[50]  Jonathan O. Harris,et al.  Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.

[51]  Taylor Dm,et al.  Resistance of scrapie agent to decontamination. , 1978 .

[52]  D. Gajdusek,et al.  Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Gajdusek,et al.  DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.

[54]  A. Devoe,et al.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.

[55]  P. Daniel,et al.  Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee , 1968, Science.

[56]  M. Alpers,et al.  Experimental Transmission of a Kuru-like Syndrome to Chimpanzees , 1966, Nature.

[57]  S. Behrman,et al.  Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). , 1960, Brain : a journal of neurology.

[58]  W. Hadlow.  SCRAPIE AND KURU , 1959 .

[59]  D. Gajdusek,et al.  Pathology of Kuru. , 1959, Laboratory investigation; a journal of technical methods and pathology.

[60]  D. Gajdusek,et al.  Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. , 1957, The New England journal of medicine.

[61]  R. D. Silva,et al.  Human Spongiform Encephalopathy , 1996 .

[62]  D. Dormont,et al.  Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. , 1994, The Journal of general virology.

[63]  H. Markus,et al.  Creutzfeldt-Jakob disease in recipients of human growth hormone in the United Kingdom: a clinical and radiographic study. , 1992, The Quarterly journal of medicine.

[64]  G. Macchi,et al.  Combination ultrafiltration and 6 M urea treatment of human growth hormone effectively minimizes risk from potential Creutzfeldt-Jakob disease virus contamination. , 1991, Hormone research.